Mixed Topics
Latest News
Redispensing unused cancer meds cuts waste, saves money
Researchers compared the reduction in drug waste and cost savings from redispensing oral anticancer drugs versus the standard practice of...
News
FDA panel voices concerns over 2 lymphoma accelerated approvals
FDA’s ODAC committee pressed for resolution on whether 2 lymphoma drugs, long on the U.S. market, actually deliver significant benefits to...
Conference Coverage
Ocular MALT lymphoma: Radiation reduces relapse
Mortality rates from early-stage ocular MALT lymphoma are low, with relapse rates lowered by radiation therapy.
News
Massive databases unleash discovery, but not so much in the U.S.
Vast medical databases have connected dots where smaller randomized trials could not. But the United States has a long way to go.
Conference Coverage
‘Why did I choose this?’ Tackling burnout in oncology
Building a sustainable oncology workforce will not be easy, but improving staffing shortages and integrating resilience training can help, experts...
Conference Coverage
The sobering facts about alcohol and cancer
An ESMO session highlights the well-known links between alcohol consumption and cancer and calls on healthcare professionals to do more to raise...
Latest News
FDA proposes ban on hair straightener ingredients
The proposal specifies that formaldehyde would be banned, as well as other chemicals that release formaldehyde, such as methylene glycol.
News
What is the future for multicancer early-detection tests?
Liquid biopsies based on genomic biomarkers could make MCED a reality, especially for cancers for which there is no standard screening process.
News
Cost concerns lead to cancer treatment delays, nonadherence
Hospital-based financial navigators may help cancer patients negotiate the intricacies of insurance coverage, experts suggest.
Latest News
These adverse events linked to improved cancer prognosis
Emerging evidence suggests that cutaneous immune-related adverse events may be linked with favorable outcomes among patients with cancer who...
